Upload Avatar (500 x 500)
阎江洪
yanjianghong@cqmu.edu.cn
中文, 英文
重庆
重庆医科大学
Basic Medical Sciences
  • 重庆医科大学优秀青年学者基金
分子肿瘤学
心血管药理学
  • Tubeimoside I Ameliorates Myocardial Ischemia-Reperfusion Injury through SIRT3-Dependent Regulation of Oxidative Stress and Apoptosis, Dingyi Lv, Minghao Luo, Zhe Cheng, Ruiyu Wang, Xiyang Yang, Yongzheng Guo, Longxiang Huang, Xiang Li, Bi Huang, Jian Shen, Suxin Luo, Jianghong Yan, 2021
  • Tubeimoside I improves endothelial function in sepsis via activation of SIRT3, Xiyang Yang, Xingbing Li, Minghao Luo, Chang Li, Longxiang Huang, Xiang Li, Bi Huang, Jiang Shen, Suxin Luo, Jianghong Yan, 2021
  • Tubeimoside I promotes angiogenesis via activation of eNOS-VEGF signaling pathway, Xiyang Yang, Xingbing Li, Minghao Luo, Yongzheng Guo, Chang Li, Dingyi Lv, Zhe Cheng, Longxiang Huang, Fei-Fei Shang, Bi Huang, Jian Shen, Suxin Luo, Jianghong Yan, 2021
  • Tubeimoside I improves survival of mice in sepsis by inhibiting inducible nitric oxide synthase expression, Minghao Luo, Suxin Luo, Zhe Cheng, Xiyang Yang, Dingyi Lv, Xingbing Li, Yongzheng Guo, Chang Li, Jianghong Yan, 2020
  • Tubeimoside I sensitizes colorectal cancer cells to chemotherapy by inducing ROS-mediated impaired autophagolysosomes accumulation, Jianghong Yan, Xiaoyun Dou, Jing Zhou, Yuanfeng Xiong, Ling Mo, Longhao Li, Yunlong Lei, 2019
癌症 肿瘤 分子生物学 肿瘤学 药理学 心血管 心脏 疾病 治疗 研究

联系我们

欢迎与我们交流!
* Required
* Required
* Required
* Invalid email address
提交此表单,即表示您同意 IoT ONE 可以与您联系并分享洞察和营销信息。
不,谢谢,我不想收到来自 IoT ONE 的任何营销电子邮件。
提交

感谢您的信息!
我们会很快与你取得联系。